Investigation and validation of cuproptosis-related ferroptosis genes in gastric cancer: Exploring the Role of MYB in the Process


Abstract

Backgrounds: Gastric cancer (GC) is a common malignant tumor of the digestive tract. Ferroptosis and cuproptosis lead to a new way of tumor cell death. The aim of this article is to search for new prognostic biomarkers for GC by combining two modes of death and to validate them experimentally.
Methods: Downloading information from the TCGA and GEO databases about patients with GC. Cuproptosis-related ferroptosis genes (CRFGs) were obtained by correlation analysis. Identify differential CRFGs and perform enrichment analysis. Prognosis-related CRFGs were detected by univariate Cox analysis. LASSO regression to build prognostic models, where the TCGA dataset is used as the train set and the GEO dataset is used as the test set. The model was validated and analyzed for TME, GSVA, immune cell infiltration, TMB, and drug sensitization. We eventually selected one of the prognosis-related CRFGs for qRT-PCR, Western blot, transwell and wound-healing assay.
Results: We obtained 155 CRFGs by correlation analysis and screened 103 from the analysis of difference. Univariate Cox analysis screened for 9 prognosis-related CRFGs. We modeled by LASSO regression and identified 7 model prognostic CRFGs (DUSP1, HIF1A, MYB, NOX4, PRKAA2, SLC2A3, and TGFBR1). The test group validates the train group well. MYB is the only gene whose expression is the opposite of the risk score, so we chose this gene for subsequent analysis. The expression of MYB in the cell lines and tissues was consistent with our bioinformatic results, but the expression levels of MYB gene are positively correlated with GC cellular growth levels, the same is true for migration and invasive capacity. Single-cell sequencing results indicate that MYB is expressed in immune cells, which may influence GC development. All meaningful delineations as p<0.05.
Conclusion: We established a novel model predicting gastric cancer prognosis based on CRFGs, identifying seven CRFGs associated with prognosis. Among these, high MYB expression promotes the development of GC cells, but its expression in immune cells may exert an inhibitory effect on gastric cancer.
Ask to review this manuscript

Notes for potential reviewers

  • Volunteering is not a guarantee that you will be asked to review. There are many reasons: reviewers must be qualified, there should be no conflicts of interest, a minimum of two reviewers have already accepted an invitation, etc.
  • This is NOT OPEN peer review. The review is single-blind, and all recommendations are sent privately to the Academic Editor handling the manuscript. All reviews are published and reviewers can choose to sign their reviews.
  • What happens after volunteering? It may be a few days before you receive an invitation to review with further instructions. You will need to accept the invitation to then become an official referee for the manuscript. If you do not receive an invitation it is for one of many possible reasons as noted above.

  • PeerJ does not judge submissions based on subjective measures such as novelty, impact or degree of advance. Effectively, reviewers are asked to comment on whether or not the submission is scientifically and technically sound and therefore deserves to join the scientific literature. Our Peer Review criteria can be found on the "Editorial Criteria" page - reviewers are specifically asked to comment on 3 broad areas: "Basic Reporting", "Experimental Design" and "Validity of the Findings".
  • Reviewers are expected to comment in a timely, professional, and constructive manner.
  • Until the article is published, reviewers must regard all information relating to the submission as strictly confidential.
  • When submitting a review, reviewers are given the option to "sign" their review (i.e. to associate their name with their comments). Otherwise, all review comments remain anonymous.
  • All reviews of published articles are published. This includes manuscript files, peer review comments, author rebuttals and revised materials.
  • Each time a decision is made by the Academic Editor, each reviewer will receive a copy of the Decision Letter (which will include the comments of all reviewers).

If you have any questions about submitting your review, please email us at [email protected].